PRESS RELEASES
Medical Microinstruments to Present at the 41st Annual J.P. Morgan Healthcare Conference
JACKSONVILLE, Fla. – January 4, 2023 – Medical Microinstruments, Inc. (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced that it will participate in the 41st Annual J.P. Morgan Healthcare Conference taking place in San Francisco, California on January 9-12, 2023. Mark Toland, Chief Executive Officer, is scheduled to present on Tuesday, January 10, 2023, at 11:30 a.m. PST / 2:30 p.m. EST at the Westin St. Francis Hotel in the Mission Bay Meeting Room. A Q&A session will follow the presentation.
About MMI
Medical Microinstruments, Inc. (MMI) was founded in 2015 near Pisa, Italy to enhance surgical performance through the development of a robotic system that enables surgeons to achieve better outcomes in microsurgery. The Symani Surgical System combines proprietary innovations including the world’s smallest wristed microinstruments as well as tremor-reducing and motion-scaling technologies. Together, these powerful capabilities allow more surgeons to successfully perform microsurgery while expanding the field of supermicrosurgery. MMI is backed by international medtech investors including Andera Partners, BioStar, Deerfield Management, Fountain Healthcare Partners, Panakès Partners, RA Capital and Sambatech.
Related News
MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani
MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential
Leading New Jersey hospital treats first patient with new robotic surgical approach to manage symptoms of breast-cancer related lymphedema
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
MMI Enrolls First Patient in Landmark U.S. Clinical Study Advancing Robotic Microsurgery
MMI Completes World’s First Robotic Microsurgical Intracranial Brain Surgery
MMI CEO Mark Toland on How the Symani Surgical System Is Redefining Robotic Microsurgery
World-first robotic throat surgery at Melbourne hospital saves patient’s voice and ability to eat
MMI’s Symani® System Redefines Robotic Microsurgery Again with First-Ever Dissection and Digital Surgery Capabilities
MMI to Present at 43rd Annual J.P. Morgan Healthcare Conference
Cedars-Sinai secures research funding to develop eye transplantation procedures to cure blindness
